Literature DB >> 1416820

Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin.

H Anwar1, J L Strap, K Chen, J W Costerton.   

Abstract

The dynamic interaction of planktonic and biofilm cells of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin was investigated in a chemostat system. The results indicated that planktonic and young biofilm cells of the 2-day-old chemostat culture of P. aeruginosa were susceptible to killing by chemostat-controlled doses of either 250 micrograms of piperacillin per ml plus 5 micrograms of tobramycin per ml or 500 micrograms of piperacillin per ml plus 5 micrograms of tobramycin per ml. Complete eradication of the planktonic and young biofilm cells was observed after exposure of the cells to six chemostat-controlled doses of these antibiotic at 8-h intervals for 7 days. Regrowth of the organism was not observed after the termination of antibiotic therapy on day 7. A different picture was observed when antibiotic treatment was initiated on day 10 after inoculation. Viable old biofilm cells were reduced to approximately 20% after exposure to the chemostat-controlled doses of 500 micrograms of piperacillin per ml plus 5 micrograms of tobramycin per ml. Complete eradication of old biofilm cells could not be achieved, and regrowth of the organism occurred after the termination of antibiotic therapy. These data suggest that young biofilm cells of mucoid P. aeruginosa can be effectively eradicated with the combination of piperacillin and tobramycin, while old biofilm cells are very resistant to these antibiotics and eradication of old biofilm cells is not achievable with the chemostat-controlled doses of piperacillin and tobramycin used in this study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1416820      PMCID: PMC190319          DOI: 10.1128/AAC.36.6.1208

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

Review 1.  Testing the susceptibility of bacteria in biofilms to antibacterial agents.

Authors:  H Anwar; M K Dasgupta; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm.

Authors:  B Giwercman; E T Jensen; N Høiby; A Kharazmi; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 3.  Influence of interfaces on microbial activity.

Authors:  M C van Loosdrecht; J Lyklema; W Norde; A J Zehnder
Journal:  Microbiol Rev       Date:  1990-03

4.  Antibiotic penetration through bacterial capsules and exopolysaccharides.

Authors:  M P Slack; W W Nichols
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

5.  Enhanced activity of combination of tobramycin and piperacillin for eradication of sessile biofilm cells of Pseudomonas aeruginosa.

Authors:  H Anwar; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

6.  The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa.

Authors:  W W Nichols; M J Evans; M P Slack; H L Walmsley
Journal:  J Gen Microbiol       Date:  1989-05

Review 7.  Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.

Authors:  T B May; D Shinabarger; R Maharaj; J Kato; L Chu; J D DeVault; S Roychoudhury; N A Zielinski; A Berry; R K Rothmel
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

8.  Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material.

Authors:  J C Nickel; I Ruseska; J B Wright; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

9.  Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.

Authors:  J Lam; R Chan; K Lam; J W Costerton
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

10.  Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology.

Authors:  M L Vasil
Journal:  J Pediatr       Date:  1986-05       Impact factor: 6.314

View more
  37 in total

1.  Nosocomial Infections in the Intensive Care Unit Associated with Invasive Medical Devices.

Authors:  Nasia Safdar; Christopher J. Crnich; Dennis G. Maki
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

2.  The MerR-like transcriptional regulator BrlR contributes to Pseudomonas aeruginosa biofilm tolerance.

Authors:  Julie Liao; Karin Sauer
Journal:  J Bacteriol       Date:  2012-06-22       Impact factor: 3.490

3.  Antimicrobial tolerance of Pseudomonas aeruginosa biofilms is activated during an early developmental stage and requires the two-component hybrid SagS.

Authors:  Kajal Gupta; Cláudia N H Marques; Olga E Petrova; Karin Sauer
Journal:  J Bacteriol       Date:  2013-08-30       Impact factor: 3.490

4.  Evaluation of several dosing regimens of cefepime, with various simulations of renal function, against clinical isolates of Pseudomonas aeruginosa in a pharmacodynamic infection model.

Authors:  D M Cappelletty
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

5.  Precipitating Pseudomonas aeruginosa antibodies and antimicrobial therapy in cystic fibrosis patients.

Authors:  M Trancassini; D de Vito; G Cimino; M Antonelli; S Quattrucci; P Cipriani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

6.  Efflux as a glutaraldehyde resistance mechanism in Pseudomonas fluorescens and Pseudomonas aeruginosa biofilms.

Authors:  Amit Vikram; Jennifer M Bomberger; Kyle J Bibby
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

7.  The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms.

Authors:  Julie Liao; Michael J Schurr; Karin Sauer
Journal:  J Bacteriol       Date:  2013-05-17       Impact factor: 3.490

8.  Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance.

Authors:  Maike Narten; Nathalie Rosin; Max Schobert; Petra Tielen
Journal:  Curr Microbiol       Date:  2011-10-08       Impact factor: 2.188

9.  Non-invasive imaging of oxygen concentration in a complex in vitro biofilm infection model using 19 F MRI: Persistence of an oxygen sink despite prolonged antibiotic therapy.

Authors:  Jeffrey W Simkins; Philip S Stewart; Sarah L Codd; Joseph D Seymour
Journal:  Magn Reson Med       Date:  2019-08-02       Impact factor: 4.668

10.  A Novel Strategy for Control of Microbial Biofilms through Generation of Biocide at the Biofilm-Surface Interface.

Authors:  P Wood; M Jones; M Bhakoo; P Gilbert
Journal:  Appl Environ Microbiol       Date:  1996-07       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.